Osteoporosis Therapeutics Market Surpasses US$14 Billion

0

USA, Rockville MD, May 15, 2022 (GLOBE NEWSWIRE) — Demand for osteoporosis treatments is expected to grow at a CAGR of 2.9% from 2022 to 2026, according to this new analysis from Fact.MR, a study market and information provider. The osteoporosis treatments market is expected to reach a valuation of $14.2 billion by the end of 2026. request Therapy for osteoporosis is expected to grow over the forecast period and the market is expected to reach a global market size of US$10.01 billion by the end of 2022.

Go through the in-depth table of contents on “Request for Therapy for osteoporosis Market”

32 paintings, 123 figures and 188 pages

Osteoporosis is a medical condition that weakens the bones and makes them brittle. This condition is very prevalent among the elderly, and as the aging population is growing across the globe at a significant rate, this will be a prime driver for market expansion. Increase in sedentary lifestyle, unhealthy eating habits and growing awareness of osteoporosis are other factors that will guide the growth of the osteoporosis treatments market over the coming years.

For critical information on North America Therapy for osteoporosis Market, demand a Sample report
https://www.factmr.com/connectus/sample?flag=S&rep_id=7285

However, the lack of diagnosis of osteoporosis and longer time taken by regulatory authorities to approve osteoporosis drugs is expected to limit the market potential of osteoporosis treatments till 2026. Manufacturers of osteoporosis drugs osteoporosis focus on new drug launches and commercialization to ensure maximum market penetration.

In April 2022, Pfenex Inc., a biotechnology company, announced the commercialization of teriparatide injection by its marketing partner Alvogen in the United States. This will be used for postmenopausal women with osteoporosis and other applications as well.

What regional markets should osteoporosis therapeutic drug providers focus on?

“North America is expected to represent the greatest therapeutic demand for osteoporosis”

The North American osteoporosis treatment market is expected to have a great outlook in the coming years and will hold a dominant market share in the global landscape.

Increase in sedentary lifestyles, increase in osteoporosis cases, presence of developed healthcare infrastructure and high potential for healthcare expenditures are expected to be major factors influencing osteoporosis drug shipments up to in 2026.

The European osteoporosis therapeutics market is expected to hold a significant market share in the global landscape throughout the forecast period. Rising expenditure on research and development activities is expected to significantly influence the market potential for osteoporosis treatments in this region.

South Asia and East Asia are expected to provide lucrative opportunities for players in the Osteoporosis Therapeutics market. Rising awareness of osteoporosis, increasing healthcare expenditure and aging population in the aforementioned regions are expected to influence the growth of the osteoporosis treatments market in a major way.

Malaysia, India and China are expected to be attractive markets for suppliers of osteoporosis drugs.

To learn more about Therapeutics of osteoporosis in Latin America Market, you can contact our analyst at https://www.factmr.com/connectus/sample?flag=AE&rep_id=7285

Key segments covered by the Therapy for osteoporosis Industry survey

  • Osteoporosis Therapeutics Market by Drug Class:
    • Bisphosphonates
    • Selective Estrogen Inhibitor Modulators (SERMs)
    • Parathyroid hormones
    • Calcitonin
    • Rank ligand inhibitors
  • Therapeutic osteoporosis Mamarket by way of administration:
    • Oral therapy for osteoporosis
    • Injectable therapy for osteoporosis
    • Other routes of administration

Competitive landscape

Osteoporosis drug makers are increasing their investment in new drug research and development to accelerate new drug launches. Osteoporosis treatment injections are gaining popularity and market players are trying to launch them to advance their revenue potential in the global market.

  • In October 2021, Entera Bio, a leading biotech company, released crucial data for its mid-stage oral osteoporosis drug formulation trial. The company has moved to Phase 3 registration of this study.

Get customization on East Asia Therapy for osteoporosis Market Report for specific search solutions
https://www.factmr.com/connectus/sample?flag=RC&rep_id=7108

The key players in the Therapy for osteoporosis Market-

  • Allergan Plc.
  • Amgen Inc.
  • Pharmaceutical Chugai
  • Daiichi Sankyo Co.Ltd.
  • Egalet Corporation
  • Eisai Co.Ltd.
  • Eli Lilly and company
  • F. Hoffmann-La Roche Ltd.

Main takeaways from South Asia and Oceania Therapy for osteoporosis Market research

  • In 2022, the global market for osteoporosis therapies stands at a net worth of US$12.7 billion.
  • The Osteoporosis Treatments Market is expected to grow at a CAGR of 2.9% from 2022 to 2026 and reach USD 14.2 billion by the end of 2026.
  • Rise in aging population and increasing prevalence of osteoporosis are major factors driving the market growth.
  • Longer approval times and lack of diagnostic equipment is expected to hamper the market potential of osteoporosis treatments to some extent till 2026.
  • In 2022, the US osteoporosis therapeutics market represents approximately 41% of the global market share.
  • The osteoporosis treatments market in China is expected to grow at a CAGR of 5.4% from 2022 to 2026.

Check out Fact.MR’s healthcare coverage –

Analysis of the antiseptics and disinfectants marketDespite growing concerns about organisms’ increasing tolerance to disinfectants, the antiseptics and disinfectants industry is growing at a faster than average rate. Antiseptics and disinfectants are now available in a variety of formulations, including sprays, ointments, wipes, gels and liquids, making them more convenient for end users to use.

Dental Infection Control Products Market Forecast The global dental infection control products market is growing rapidly, driven by the increased demand for dental care products. This increase in demand is due to an increase in the incidence of oral diseases, a growing geriatric population with caries problems and changing lifestyles and dietary habits.

Dental consumables market sizeThe dental consumables market is expected to grow steadily through 2030, driven by increasing cases of dental problems and demand for invasive dental procedures. The increase in dental tourism in developing countries like China and India, as well as the increase in the elderly population, are all contributing to this trend.

Growth of the dental restorations market Dental care requirements have led to a dramatic shift in the type of dental care services from traditional restorative care to cosmetic and preventative care. Generic factors, such as increasing dental difficulties among the elderly, growing dental tourism, and increasing number of certified practitioners are expected to drive the dental restorations market.

About Us:
Market research and consulting agency that makes the difference! That’s why 80% of Fortune 1000 companies trust us to make their most critical decisions. Although our experienced consultants use the latest technology to extract hard-to-find information, we believe that our USP is the trust our clients place in our expertise. Covering a wide spectrum – from automotive and Industry 4.0 to healthcare and retail, our coverage is extensive, but we ensure that even the most niche categories are analyzed. Our sales offices in the USA and Dublin, Ireland. Headquarters based in Dubai, United Arab Emirates. Contact us with your goals and we will be a competent research partner.

Contact:
Mahendra Singh
Japan Sales Office
4-1-1 Nakano,
9F Nakano Sunplaza
Tokyo, 164-8512
Japan
E: [email protected]

Share.

About Author

Comments are closed.